Introduction

Assessment of myocardial sympathetic denervation utilizing radionuclide norepinephrine analog tracers such as 11C-hydroxyephedrine (11C-HED) and 123I-meta-iodobenzylguanidine (123I-MIBG) has emerged as one of the most promising techniques for risk stratification for sudden cardiac death in patients with heart failure and ischemic cardiomyopathy [13]. In the most recent clinical trial called PAREPET, 11C-HED PET was used for identifying local cardiac sympathetic nerve damage, and demonstrated independent prognostic value in predicting a high risk of sudden cardiac death [3]. This may provide support for the identification of heart failure patients most likely to benefit from an implantable cardiac defibrillator, since left ventricular ejection fraction alone is not yet sufficient to identify appropriate candidates [4, 5].

The cardiac sympathetic nerve system is known to be more sensitive to ischemic insult than cardiac myocytes. In animal experimental studies, temporal damage to the cardiac sympathetic nerves after transient ischemia has been shown [613]. In humans, several imaging studies using radiolabeled norepinephrine analog tracers have confirmed sympathetic nerve alterations, which are correlated with the area of ischemia in acute coronary syndrome [14]. In the present investigation, in order to improve the understanding of regional and temporal changes in the condition of the sympathetic nerves after transient ischemic injury, we used a well-established rat model of left coronary occlusion and reperfusion [15, 16]. We studied this model with the radionuclide PET tracer 11C-HED [17, 18].

Materials and methods

Animal experiments in a rat model of ischemia (12 animals) and healthy control rats (6 animals) were conducted using 11C-HED and 201TI dual-tracer autoradiography. Additionally, two rats underwent three in vivo PET sessions before ischemia, and in the subacute and chronic phases of ischemia (Fig. 1). Animal protocols were approved by the local institutional animal care and use committee and were conducted according to the Guide for the Care and Use of Laboratory Animals.

Fig. 1
figure 1

Schematic diagram illustrating the protocol for the rat model of ischemia (LCA left coronary artery)

Radiopharmaceuticals

11C-HED was synthesized as previously described [19] and showed specific radioactivities of > 6 GBq/µmol and radiochemical purity of >98 %. 201TI was purchased from GE Healthcare. 18F-FDG was synthesized in our in-house cyclotron according to the manufacturer’s instructions.

Animal model of transient myocardial ischemia

For our experiments male Wistar rats (Charles River Laboratories) were used. Transient myocardial ischemia was performed as previously described [20, 21]. Under general anesthesia with 2 % isoflurane, ischemia was induced by ligating the left coronary artery with a 7-0 polypropylene suture for 20 min via a left lateral thoracotomy. Reperfusion was accomplished by releasing the ligature. The success of coronary occlusion and reperfusion was verified visually by regional cyanosis and blush of the myocardial surface. After closure of their chest, the animals were allowed to recover with appropriate pain medication for postoperative analgesia.

Dual-tracer autoradiography study

Dual-tracer autoradiography of the left ventricular short-axis slices was performed to assess both 11C-HED uptake for sympathetic innervation and 201Tl uptake for reference perfusion. Three groups of animals were studied: (1) subacute phase (day 7 after ischemia, five animals), (2) chronic phase (2 months after ischemia, six animals), and (3) healthy control rats without ischemia (six animals). Both 11C-HED (74 MBq) and 201Tl (0.74 MBq) were injected via a tail vein 20 min and 5 min before the rats were killed. The heart was then extracted, frozen and cut into 20-μm short axis slices using a cryostat. Immediately afterwards, the autoradiography plate (MultiSensitive phosphor screen; PerkinElmer) was first exposed to the slices for 45 min for visualization of 11C-HED distribution with a digital autoradiography system (CR 35 Bio, Raytest or Cyclone; Packard). After 12 h to allow complete decay of 11C, a second exposure to visualize 201Tl distribution was continued for 1 week [17].

In order to quantify tracer uptake distribution, regions of interest (ROIs) were drawn on the anterolateral area at risk of ischemia (25 % of circumference) and a remote control region (opposite 25 % of circumference) on a midmyocardial short-axis section. In order to assess the transmural pattern of tracer distribution in the ventricular wall, the ROIs were divided into subepicardial (inner half) and subendocardial (outer half) wall portions on the slices (Fig. 2). Areas of tracer uptake defect were determined using a threshold of 50 % of maximum myocardial activity on a midventricular short axis slice. Then the uptake defect areas were calculated as percentages in relation to the area of the left ventricular short-axis slice. After autoradiographic exposure, the short axis tissue slices were stained with hematoxylin and eosin (HE) using a standard procedure. The infarct scar area was determined using manual planimetric measurement of the HE staining on digitized photographs.

Fig. 2
figure 2

a Representative cross-sectional short-axis images at the midventricular level on dual-tracer autoradiography with 11C-HED and 201Tl after transient coronary occlusion and reperfusion. The area of the transmural 11C-HED defect (asterisk) is larger than that of the 201Tl defect 1 week after ischemia. In contrast, the nontransmural 11C-HED uptake defect shows restored uptake at the subepicardial lesion (arrowheads) in the chronic phase. b Graphs indicate the tracer defect area as a percentage of the left ventricular short-axis slice and the average tracer uptake ratios. The area of the 11C-HED uptake defect was significantly smaller in the chronic phase than in the subacute phase (*p < 0.01). 11C-HED uptake in the subepicardial portion is significantly higher than in subendocardial portion in the ischemic area in chronic phase (*p < 0.01). ANT anterior wall, POST posterior wall, RV right ventricle, LV left ventricle, ROI region of interest

Histological tissue analysis of the nerve was performed with 7-μm slices adjacent to the cross-sectional left ventricular short-axis slices used for autoradiography analysis. Immunofluorescence staining of catecholaminergic neurons using standard techniques and commercially available rabbit polyclonal ab6211 tyrosine hydroxylase (TH) antibodies (Abcam) was performed. Digitized images were obtained using a fluorescence microscope (model BZ-9000; Keyence) with standardized illumination and contrast. To quantify the percentage of the area with positive TH staining, three fields were randomly selected from 11C-HED uptake-positive and uptake-negative areas on autoradiographic images. The average percentage positive area from the fields was then calculated using BZ-II analyzer software by adjusting the fluorescence intensity threshold of the software so that the visually identified nerve fibers were appropriately selected as closely as possible.

In vivo PET imaging

A dedicated microPET scanner (Inveon: Siemens) was used to perform serial in vivo cardiac 11C-HED and 18F-FDG PET scans both 1 week and 2 months after myocardial ischemia (two animals). Initially, 10 min after intravenous injection of 37 MBq 11C-HED, static images were acquired over 20 min. As a reference, a second scan with 18F-FDG was performed after more than four half-lives of 11C decay. Starting 60 min after intravenous administration of 37 MBq of 18F-FDG, static PET images were acquired over 15 min.

Statistical analysis

Results are presented as means ± SD. The two-tailed paired Student’s t test was used to compare differences between two dependent groups and the two-tailed independent Student’s t test between independent groups. Values of p <0.05 were considered statistically significant.

Results

Dual-tracer autoradiography

In dual-tracer autoradiography, both 11C-HED and 201TI were distributed throughout the healthy myocardium of the left ventricle (Fig. 2). After transient ischemia, the area of reduced 11C-HED uptake was found to be larger than the 201Tl defect area in both the subacute and chronic phases after ischemia. The 11C-HED defect area in the left ventricular short-axis slices in the subacute phase (31.7 ± 11.2 %) was significantly larger than in the chronic phase (13.8 ± 6.7 %, p < 0.01). The 201TI uptake defect areas in both the subacute and chronic phases (5.7 ± 5.2 % and 2.1 ± 1.2 %, respectively) were significantly smaller than the 11C-HED defect area (p < 0.01 and p < 0.05, respectively). There were no significant differences between the 201TI uptake defect areas and the scar areas identified on HE staining (scar areas 5.8 ± 5.4 % and 3.0 ± 1.3 % in the subacute and chronic phases, respectively). Interestingly, the transmural pattern of the 11C-HED defect was different between the subacute and chronic phases. The defect was transmural in the subacute phase and 11C-HED activity in the subepicardium was restored in the chronic phase. 11C-HED uptake ratios (vs. the remote control region) in the subendocardial and subepicardial portions were 0.25 ± 0.08 and 0.24 ± 0.11 (not significantly different) in the subacute phase, and 0.58 ± 0.08 and 0.77 ± 0.12 (p < 0.01) in the chronic phase, respectively. On the other hand, the 201Tl uptake ratios -positive fibers was well matched with the area of 11C-HED uptake in both the subacute and chronic phases (Fig. 3). TH-immunopositive nerve densities in the 11C-HED-positive and 11C-HED-negative areas were significantly different in both the subacute phase (0.51 ± 0.27 % vs. 0.15 ± 0.11 %, p < 0.05) and the chronic phase (0.67 ± 0.20 % vs. 0.07 ± 0.08 %, p < 0.01).

Fig. 3
figure 3

a Representative images showing tyrosine hydroxylase immunofluorescence staining in the 11C-HED defect area (HED (-)) and a remote control area (HED (+)) in the left ventricular wall in the subacute and chronic phases after transient ischemia in a rat model. b There is an extensive reduction in TH-positive cells in 11C-HED defect areas in both the subacute and chronic phases after ischemia (*p < 0.05, **p < 0.01, vs. HED (-))

In vivo PET imaging

In vivo PET imaging visualized the 11C-HED defect corresponding to the ex vivo autoradiographic findings after ischemia. 18F-FDG uptake was preserved throughout the ventricle, indicating preserved myocardial viability at the 11C-HED defect area. Furthermore, the reduction in the 11C-HED defect area in the chronic phase after ischemia was confirmed on serial imaging (Fig. 4).

Fig. 4
figure 4

In vivo serial PET imaging with 11C-HED and 18F-FDG in a rat model before and after transient ischemia. The regional 11C-HED uptake defect (arrows) with preserved 18F-FDG uptake is seen only after ischemia. The defect in 11C-HED uptake at 1 week is reduced at 2 months

Discussion

The present study investigated regional patterns of sympathetic nerve degradation and restoration utilizing the radionuclide PET tracer 11C-HED after 20 min of transient ischemia in a rat model. Transmural 11C-HED uptake defects in the subacute phase and partial subepicardial recovery of 11C-HED uptake in the chronic phase were visualized autoradiographically. These regional 11C-HED uptake findings showed a close correlation with sympathetic denervation as determined by TH immunofluorescence staining. Furthermore, using dual-tracer autoradiography, preserved uptake of 201Tl in the 11C-HED defect areas confirmed myocardial viability and excluded abnormalities of myocardial perfusion as a cause of decreased 11C-HED uptake. Additionally, in vivo serial PET imaging visualized the changes in the 11C-HED defect noninvasively. To the best of our knowledge, this is the first demonstration of 11C-HED distribution patterns in histologically confirmed areas of denervation and reinnervation of the heart after transient ischemia.

11C-HED is one of the most widely used PET tracers for determining the innervation in the heart. High affinity for the norepinephrine transporter is well characterized in several species including rodents and humans [17, 20]. Although rats are commonly used animals for studying cardiac diseases, there are significant differences in myocardial norepinephrine handling between rats and humans. In addition to the common reuptake mechanism transporting norepinephrine at the nerve terminal (uptake 1), the nonneural uptake system (uptake 2) plays an important role in the rat heart. This mechanism transports norepinephrine into the myocytes and this is followed by enzymatic degradation, which is not considered to be relevant in the human heart. To fully characterize the sympathetic nerve system, the specific properties of commonly used norepinephrine analog tracers related to animal models must be taken into consideration. The specificity of the two most commonly used clinical radiolabeled nerve tracers, 123I-MIBG and 11C-HED, have been tested in rat hearts [17]. Cardiac 11C-HED uptake showed very high specificity for neural uptake 1, which was confirmed by desipramine blockage of more than 90 %. However, 123I-MIBG uptake demonstrated a significant contribution from nonneural uptake 2, which was confirmed by desipramine and phenoxybenzamine (uptake 1 and 2 blockage) blocking studies. Similar results have been reported for the nonneural uptake of the recently introduced 18F-labeled PET tracer, LMI1195, that is similar to MIBG being based on a benzylguanidine structure [21].

It has been reported that myocardial ischemia can cause sympathetic nerve damage that is thought to play a critical role in ventricular arrhythomogenesis [22, 23]. Studies in dogs have shown that a hypoxic environment at the myocardial peri-infarction zone can cause functional denervation with the generation of viable but denervated myocardial tissue [6]. Imaging approaches have confirmed corresponding findings in human hearts. Larger areas of sympathetic neuronal damage measured by 123I-MIBG uptake were well matched to areas of myocardium at risk in patients with acute coronary syndrome after revascularization [14]. A recent clinical trial further indicated the clinical significance of 11C-HED PET-derived denervation as a significant predictor of sudden cardiac death [3]. Denervated myocardial tissue may contribute to the earliest endocardial activation of ventricular tachycardia, as suggested in pig experimental models of myocardial infarction [24]. We successfully replicated and visualized viable but denervated myocardial tissue in a rat model after 20 min of transient ischemia. Larger 11C-HED defects exceeding the area of the hypoperfused scar were demonstrated with a dual tracer autoradiography assay. Further histological analyses confirmed anatomical denervation corresponding to the area of the 11C-HED defect. These results are in line with previous findings in humans and large animals demonstrating higher susceptibility of nerve cells to ischemic injury than myocytes [14]. It should be noted that the present experimental set-up by utilizing a small-animal model had a number of advantages such as cost-effectiveness, easier handling and higher reproducibility.

Reinnervation of the ischemically denervated tissue in patients with acute coronary syndrome has been suggested but has still not been conclusively shown. In an early experiment with large animals, Minardo et al. confirmed sympathetic reinnervation by complete restoration of 123I-MIBG uptake correlating with electrophysiological responses 14 weeks after myocardial infarction or phenol denervation treatment [25]. In contrast, Fallavollita et al. did not find any change in defect size after revascularization of reversibly ischemic myocardium in swine with hibernating myocardium over 4 weeks using 11C-HED PET [26]. In human hearts, slow (after >18 months) but progressive reinnervation has been shown by various approaches including PET imaging in patients after heart transplantation [27]. However, clinical reports of reinnervation of viable but denervated myocardial tissue in patients with ischemic heart disease are very limited and inconsistent.

Allman et al. studied 16 patients with a first acute myocardial infarction who had serial 11C-HED PET and ammonia perfusion imaging performed at 7 days and 8 months, but no change in the 11C-HED abnormalities was observed [13]. On the other hand, Hartikainen et al. studied 13 patients using 123I-MIBG SPECT and perfusion scintigraphy and found partial reinnervation at the peri-infarction zone between 3 and 12 months [12]. The present study using a rat model of transient coronary occlusion and reperfusion confirmed significant anatomical reinnervation and corresponding recovery of 11C-HED uptake in the area at risk. One of the limitations of the present study was the small size of the rodent heart. Further correlative studies using a large-animal model are warranted to provide a better understanding of the dynamics of sympathetic reinnervation in the human heart.

Interestingly, the present results show that the reinnervation was limited to the subepicardial portion of the myocardium. This spatial pattern of reinnervation might be partly explained by the anatomy of sympathetic nerve distribution in the heart. Sympathetic nerve fibers first travel along the surface of the heart accompanying pericardial vascular structures and then penetrate the myocardium from the epicardial side [28]. Therefore, it is plausible that the reinnervation process starts in the epicardium. Furthermore, blocking of sympathetic nerve regeneration by inhibitory components of the extracellular matrix has recently been reported [8]. The presence of endocardial nontransmural scar tissue may be one factor contributing to the inhibition of further nerve growth towards the distal endocardial portion of the ventricle.

We employed only a midventricular slice from each heart for the autoradiographic analysis instead of using multiple slices from the entire heart. Infarct size and defect area expressed as a percentage of the whole left ventricular area cannot be accurately assessed. This is because of the methodological limitation of using a tracer with very short physiological half-life (11C, T ½ 20 min). This requires prompt exposure of the sliced samples before radioactive decay. However, we also note that the difference in radioactive decay of the two tracers in our dual-tracer assay was of value in the analysis. The distribution of 201Tl (T ½ 74 h) could also be analyzed as a reference in exactly same tissue slices, which strengthened the results relating to 11C-HED distribution.

In conclusion, we investigated sympathetic nerve damage and regeneration utilizing a rat model of myocardial transient ischemia and a catecholamine analog PET tracer, 11C-HED. Our results confirmed that sympathetic neurons are more susceptible to ischemic injury than myocytes. Additionally, reinnervation was shown by differences in the pattern of 11C-HED distribution in the subacute and the chronic phases. This discrepancy in 11C-HED distribution was confirmed by initial transmural denervation in the subacute phase followed by partial subepicardial nerve restoration in the area at risk during the chronic phase.